Pharmacokinetics of mycophenolate sodium and comparison with the mofetil formulation in stable kidney transplant recipients.

@article{Cattaneo2007PharmacokineticsOM,
  title={Pharmacokinetics of mycophenolate sodium and comparison with the mofetil formulation in stable kidney transplant recipients.},
  author={Dario Cattaneo and Monica Cortinovis and Sara Baldelli and Alessandra Bitto and Eliana Gotti and Giuseppe Remuzzi and Norberto Perico},
  journal={Clinical journal of the American Society of Nephrology : CJASN},
  year={2007},
  volume={2 6},
  pages={
          1147-55
        }
}
BACKGROUND AND OBJECTIVES The introduction of mycophenolate mofetil has improved graft survival after organ transplantation; however, its use may be limited by important adverse effects. For overcoming these problems, an enteric-coated formulation of mycophenolate sodium has been developed, but pharmacokinetic data of mycophenolic acid release from this formulation are scanty. DESIGN, SETTING, PARTICIPANTS, & MEASUREMENTS Pharmacokinetic studies in 32 kidney transplant recipients who were… CONTINUE READING

Citations

Publications citing this paper.
SHOWING 1-10 OF 21 CITATIONS

Mycophenolate revisited.

  • Transplant international : official journal of the European Society for Organ Transplantation
  • 2015
VIEW 1 EXCERPT
CITES BACKGROUND

References

Publications referenced by this paper.
SHOWING 1-10 OF 25 REFERENCES

Pharmacokinetic and pharmacodynamic comparison of enteric-coated mycophenolate sodium and mycophenolate mofetil in maintenance renal transplant patients.

  • American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons
  • 2007
VIEW 3 EXCERPTS

Therapeutic drug monitoring of MMF: A randomized multicenter study comparing concentration controlled versus fixed dose in kidney transplant recipients

Y Le Meur, M Buchler, +3 authors A Thierry
  • Transplantation
  • 2006
VIEW 1 EXCERPT